Mariana Mihalusova

Venrock promoted Mariana Mihalusova from Principal to Partner. Venrock focuses on early-stage investments in healthcare and technology. She joined Venrock in 2020 after nearly a decade at Celgene and Bristol Myers Squibb, where she led programs across hematology, oncology, immunology and neurodegeneration; at Venrock she helped found Interdict Bio and serves on several biotech boards. More here →